Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Arvinas in a report issued on Wednesday, February 12th. HC Wainwright analyst A. Fein forecasts ...

H.C. Wainwright analyst Heiko Ihle reiterates a Buy rating on Hecla Mining (HL) shares after the company reported 2024 financial results. The ...

Investment analysts at HC Wainwright dropped their Q2 2025 earnings estimates for Enanta Pharmaceuticals in a report released on Tuesday, February 11th. HC Wainwright analyst E. Arce now expects that ...

Ocugen (OCGN) is climbing 5% after investment bank H.C. Wainwright raised its price target on the shares to $8 from $7.

H.C. Wainwright analyst Patrick Trucchio revised the price target on Compass Pathways (NASDAQ:CMPS) stock, reducing it to $45 ...

H.C. Wainwright analyst Emily Bodnar increased the price target on AnaptysBio (NASDAQ:ANAB) shares to $22.00, up from the previous $19.00, while maintaining a Neutral rating on the stock. According to ...

H.C. Wainwright analyst Patrick Trucchio lowered the firm’s price target on Cybin (CYBN) to $150 from $190 and keeps a Buy rating on the ...

H.C. Wainwright estimates Knightscope’s near-term market opportunity at $4 billion, with long-term industry potential exceeding $41 billion in recurring revenue. "Following strategic corporate ...

--(BUSINESS WIRE)--Knightscope, Inc. (NASDAQ: KSCP), an innovator in robotics and artificial intelligence technologies focused on public safety, today announced that H.C. Wainwright & Co. has ...

MOUNTAIN VIEW, Calif., January 31, 2025--(BUSINESS WIRE)--Knightscope, Inc. (NASDAQ: KSCP), an innovator in robotics and artificial intelligence technologies focused on public safety, today announced ...